HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rossella Liani Selected Research

11-dehydro-thromboxane B2

1/2020In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance.
12/2018Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis.
11/2016Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitus.
7/2014Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rossella Liani Research Topics

Disease

11Inflammation (Inflammations)
11/2022 - 01/2011
8Type 2 Diabetes Mellitus (MODY)
11/2022 - 07/2014
6Thrombosis (Thrombus)
01/2020 - 09/2012
5Insulin Resistance
01/2021 - 07/2015
4Prediabetic State (Prediabetes)
11/2022 - 12/2018
3Body Weight (Weight, Body)
11/2022 - 12/2018
3Weight Loss (Weight Reduction)
11/2022 - 12/2018
3Glucose Intolerance
11/2022 - 10/2014
2Metabolic Diseases (Metabolic Disease)
01/2020 - 09/2012
2Obesity
12/2018 - 09/2012
1Fibrosis (Cirrhosis)
11/2022
1Neoplasm Metastasis (Metastasis)
02/2017
1Breast Neoplasms (Breast Cancer)
02/2017
1Neoplasms (Cancer)
02/2017
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2016
1Necrosis
01/2016
1Hyperglycemia
07/2015
1Leg Ulcer
10/2014
1Atherosclerosis
07/2014
1Diabetes Mellitus
07/2014
1Acute Coronary Syndrome
07/2014
1Myocardial Ischemia (Ischemic Heart Diseases)
07/2014
1Vascular Diseases (Vascular Disease)
09/2012
1Hypercholesterolemia
01/2011

Drug/Important Bio-Agent (IBA)

10ThromboxanesIBA
01/2020 - 01/2011
7Glucose (Dextrose)FDA LinkGeneric
11/2022 - 07/2014
5CD40 Ligand (CD40L)IBA
01/2016 - 04/2012
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
07/2015 - 02/2011
4Metformin (Glucophage)FDA LinkGeneric
11/2022 - 12/2018
411-dehydro-thromboxane B2IBA
01/2020 - 07/2014
4Proteins (Proteins, Gene)FDA Link
11/2016 - 12/2013
3LiraglutideFDA Link
11/2022 - 12/2018
3Biomarkers (Surrogate Marker)IBA
11/2022 - 02/2017
3Receptor for Advanced Glycation End ProductsIBA
07/2015 - 09/2012
2IsoprostanesIBA
12/2018 - 12/2013
2N,N-dimethylarginine (asymmetric dimethylarginine)IBA
11/2016 - 07/2014
2Insulin (Novolin)FDA Link
11/2016 - 10/2016
2CytokinesIBA
10/2016 - 07/2015
1Glucagon-Like Peptide 1 (GLP 1)IBA
11/2022
1Pharmaceutical PreparationsIBA
11/2022
1Galectin 3 (LGALS3)IBA
11/2022
1Galectins (Galectin)IBA
11/2022
1LipidsIBA
01/2021
1IncretinsIBA
12/2018
1Glucagon-Like Peptide ReceptorsIBA
12/2018
1C-Reactive ProteinIBA
12/2018
1Cyclooxygenase 1IBA
12/2018
1Phenobarbital (Luminal)FDA Link
02/2017
1Oxidants (Oxidizing Agents)IBA
02/2017
1Estrogens (Estrogen)FDA Link
02/2017
1AcarboseFDA LinkGeneric
11/2016
1GlucosidasesIBA
11/2016
1ResistinIBA
11/2016
1Rosiglitazone (Avandia)FDA Link
11/2016
1AdipokinesIBA
11/2016
1Lymphotoxin-alpha (Lymphotoxin)IBA
10/2016
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
10/2016
1Messenger RNA (mRNA)IBA
10/2016
1Infliximab (Remicade)FDA Link
01/2016
1F2-Isoprostanes (F2 Isoprostanes)IBA
01/2016
1ChemokinesIBA
07/2015
1HDL LipoproteinsIBA
12/2013
1P-SelectinIBA
12/2013
1Iloprost (Ventavis)FDA Link
02/2011
1Atorvastatin (Lipitor)FDA Link
01/2011
1Rosuvastatin Calcium (Crestor)FDA Link
01/2011

Therapy/Procedure

3Glycemic Control
11/2022 - 12/2018
1Therapeutics
12/2018